124,000 Shares in Kenvue Inc. $KVUE Acquired by CIBRA Capital Ltd

CIBRA Capital Ltd bought a new stake in Kenvue Inc. (NYSE:KVUE) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 124,000 shares of the company’s stock, valued at approximately $2,139,000. Kenvue accounts for about 3.7% of CIBRA Capital Ltd’s investment portfolio, making the stock its 12th biggest holding.

Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. Salomon & Ludwin LLC purchased a new position in shares of Kenvue in the 3rd quarter worth $25,000. NBT Bank N A NY increased its stake in Kenvue by 180.3% during the third quarter. NBT Bank N A NY now owns 1,564 shares of the company’s stock worth $25,000 after acquiring an additional 1,006 shares during the last quarter. Cornerstone Planning Group LLC increased its stake in Kenvue by 705.2% during the third quarter. Cornerstone Planning Group LLC now owns 1,554 shares of the company’s stock worth $25,000 after acquiring an additional 1,361 shares during the last quarter. Golden State Wealth Management LLC raised its holdings in shares of Kenvue by 150.1% in the 3rd quarter. Golden State Wealth Management LLC now owns 1,983 shares of the company’s stock worth $32,000 after purchasing an additional 1,190 shares during the period. Finally, Trust Co. of Vermont raised its holdings in shares of Kenvue by 50.9% in the 3rd quarter. Trust Co. of Vermont now owns 2,385 shares of the company’s stock worth $39,000 after purchasing an additional 804 shares during the period. Institutional investors and hedge funds own 97.64% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on the company. Weiss Ratings reiterated a “hold (c-)” rating on shares of Kenvue in a report on Friday, January 9th. Jefferies Financial Group lowered shares of Kenvue from a “buy” rating to a “hold” rating and cut their price target for the company from $23.00 to $18.00 in a report on Friday, January 30th. UBS Group lifted their price target on shares of Kenvue from $17.00 to $19.00 and gave the company a “neutral” rating in a research report on Wednesday, February 18th. Citigroup boosted their price objective on shares of Kenvue from $18.00 to $20.00 and gave the stock a “neutral” rating in a research note on Wednesday, February 18th. Finally, Argus raised shares of Kenvue to a “hold” rating in a research report on Friday, March 6th. Three analysts have rated the stock with a Buy rating and thirteen have given a Hold rating to the stock. According to data from MarketBeat, Kenvue presently has an average rating of “Hold” and a consensus price target of $19.58.

Kenvue Price Performance

Shares of NYSE KVUE opened at $17.52 on Friday. Kenvue Inc. has a 1-year low of $14.02 and a 1-year high of $25.17. The business has a 50-day moving average of $18.01 and a 200-day moving average of $17.13. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.96 and a quick ratio of 0.68. The company has a market capitalization of $33.57 billion, a price-to-earnings ratio of 22.75, a PEG ratio of 3.98 and a beta of 0.51.

Kenvue (NYSE:KVUE) last announced its earnings results on Tuesday, February 17th. The company reported $0.27 EPS for the quarter, beating the consensus estimate of $0.22 by $0.05. The business had revenue of $3.78 billion for the quarter, compared to the consensus estimate of $3.68 billion. Kenvue had a return on equity of 19.72% and a net margin of 9.72%.The company’s revenue was up 3.2% on a year-over-year basis. During the same period last year, the business posted $0.26 EPS. On average, equities analysts anticipate that Kenvue Inc. will post 1.14 EPS for the current fiscal year.

Kenvue Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, February 25th. Stockholders of record on Wednesday, February 11th were paid a $0.2075 dividend. The ex-dividend date was Wednesday, February 11th. This represents a $0.83 annualized dividend and a dividend yield of 4.7%. Kenvue’s dividend payout ratio is 107.79%.

Kenvue Company Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.